Skip to main content

Xometry, Inc. (XMTR) Stock Forecast 2025 - AI Price Prediction & Analysis


Xometry, Inc. (XMTR) AI Stock Price Forecast & Investment Analysis

Xometry, Inc. Stock Price Chart and Technical Analysis

Loading Xometry, Inc. interactive price chart and technical analysis...

Xometry, Inc. (XMTR) - Comprehensive Stock Analysis & Investment Research

Deep dive into Xometry, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Xometry, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Xometry, Inc.: Xometry, Inc. operates in the Trade & Services sector, establishing it as a mid-cap growth opportunity.

Xometry, Inc. (Stock Symbol: XMTR) is a leading company in the Trade & Services sector , specifically operating within the Services-Business Services, NEC industry.

The organization employs approximately 386 professionals worldwide .

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Xometry, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Xometry, Inc.: With $258M in annual revenue and -27.5% net margin, the company demonstrates developing profitability.

Annual Revenue: $258 million generating a -27.5% net profit margin .

Market Capitalization: $2480 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): -49.1% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Xometry, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Xometry, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Xometry, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Xometry, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Xometry, Inc.: Market positioning analysis based on available financial and operational metrics.

Xometry, Inc. strategically competes in the highly dynamic Services-Business Services, NEC marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

The company maintains a healthy 31.1% gross margin, indicating strong pricing power and operational efficiency.

Xometry, Inc. (XMTR) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Xometry, Inc. stock analysis.

Loading Xometry, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Xometry, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Xometry, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Xometry, Inc.: With a P/E ratio of -24.72, the market sees the stock as potentially undervalued.

P/E Ratio -24.72x
P/B Ratio 7.89x
Market Cap $2480M
EPS $-1.51
Book Value/Share $6.41
Revenue/Share $5.49
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Xometry, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Xometry, Inc.: An ROE of -49.1% indicates room for improvement in shareholder value creation.

ROE -49.1%
ROA -16.8%
ROIC -23.3%
Gross Margin 31.1%
Operating Margin -26.2%
Net Margin -27.5%
EBT Margin -27.7%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Xometry, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Xometry, Inc.: A current ratio of 7.86 indicates strong liquidity.

Current Ratio 7.86x
Quick Ratio 7.57x
D/E Ratio 0.72x
Financial Leverage 1.86x
Interest Coverage -54.3x
Working Capital $39M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Xometry, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Xometry, Inc.: Free cash flow of $-90M indicates cash challenges that need attention.

Operating Cash Flow $-83M
Free Cash Flow $-90M
Capital Spending $-8M
FCF/Sales -35.1%
CapEx/Sales 2.9%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Xometry, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Xometry, Inc.: An asset turnover of 0.61x suggests room for improvement in asset utilization.

Asset Turnover 0.61x
Receivables Turnover 8.8x
Inventory Turnover 96.3x
Fixed Assets Turnover 11.4x
Days Sales Outstanding 41 days
Days Inventory 4 days
Payables Period 18 days
Cash Conversion Cycle 27 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Xometry, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Xometry, Inc.: With annual revenue of $258M, Xometry, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $258M
R&D Expense $38M
SG&A Expense $37M
Cost of Goods Sold $69M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 56%
Cash & Short-term Investments 48%
Total Liabilities 46%
Short-term Debt 15%
Accounts Receivable 5%
Inventory 0%
Dividend & Shareholder Information
Shares Outstanding 49M

Latest Xometry, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Xometry, Inc. (XMTR) stock price and investment outlook.

, source: Markets Insider

NORTH BETHESDA, Md., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Xometry, Inc. (NASDAQ:XMTR), the global AI-powered marketplace connecting buyers with suppliers of manufacturing services, announced that members ...

, source: Seeking Alpha

Good day and thank you for standing by. Welcome to the Xometry Q2 2024 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like ...

, source: ETF Daily News

Nuveen LLC acquired a new stake in Xometry, Inc. (NASDAQ:XMTR – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 587,440 ...

, source: Seeking Alpha

Good day and thank you for standing by. Welcome to the Xometry Q2 2023 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a ...

Xometry, Inc. Competitors & Peer Analysis - Trade & Services Sector

Comparative analysis of Xometry, Inc. against industry peers and competitors in the Trade & Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ACN Unlock Forecast - 30 Days FREE Trial $156686M 20.6x 5.0x
ACVA Unlock Forecast - 30 Days FREE Trial $1511M -45.1x 3.4x
AFBL Unlock Forecast - 30 Days FREE Trial $40M x x
AKAM Unlock Forecast - 30 Days FREE Trial $10455M 26.4x 2.3x
ALIT Unlock Forecast - 30 Days FREE Trial $1522M -13.8x 0.5x
AMTM Unlock Forecast - 30 Days FREE Trial $5227M 216.7x 1.2x
AMWL Unlock Forecast - 30 Days FREE Trial $90M -1.7x 0.3x
ASFH Unlock Forecast - 30 Days FREE Trial $63M x 33.0x
BABA Unlock Forecast - 30 Days FREE Trial $3324808M x 3.3x
BABAF Unlock Forecast - 30 Days FREE Trial $390730M x 0.4x
BAER Unlock Forecast - 30 Days FREE Trial $92M -3.0x -0.3x
BAOS Unlock Forecast - 30 Days FREE Trial $5M x 0.1x
BCRD Unlock Forecast - 30 Days FREE Trial $107M x 13.1x
BR Unlock Forecast - 30 Days FREE Trial $25748M 32.4x 9.7x
CART Unlock Forecast - 30 Days FREE Trial $9956M 21.4x 3.0x
CASS Unlock Forecast - 30 Days FREE Trial $522M 19.9x 2.2x
CBZ Unlock Forecast - 30 Days FREE Trial $3282M 31.3x 1.7x
CCCP Unlock Forecast - 30 Days FREE Trial $0M x x
CJMB Unlock Forecast - 30 Days FREE Trial $19M x 3.3x
CNDT Unlock Forecast - 30 Days FREE Trial $382M 20.7x 0.5x
CNXC Unlock Forecast - 30 Days FREE Trial $2653M 9.3x 0.6x
CPAY Unlock Forecast - 30 Days FREE Trial $18931M 19.3x 4.8x
CSGP Unlock Forecast - 30 Days FREE Trial $29382M 310.6x 3.4x
CTEV Unlock Forecast - 30 Days FREE Trial $1119M x 47.4x
DASH Unlock Forecast - 30 Days FREE Trial $116263M 142.5x 13.0x
DBMM Unlock Forecast - 30 Days FREE Trial $1M x x
DHX Unlock Forecast - 30 Days FREE Trial $101M 55.6x 1.0x
DVLT Unlock Forecast - 30 Days FREE Trial $231M x 3.1x
DWIS Unlock Forecast - 30 Days FREE Trial $19M x x
EBAY Unlock Forecast - 30 Days FREE Trial $45689M 20.7x 9.6x
EDXC Unlock Forecast - 30 Days FREE Trial $1M x x
EEX Unlock Forecast - 30 Days FREE Trial $899M 117.8x 2.3x
ETSY Unlock Forecast - 30 Days FREE Trial $6425M 45.2x -6.9x
EXLS Unlock Forecast - 30 Days FREE Trial $6123M 28.3x 6.4x
FI Unlock Forecast - 30 Days FREE Trial $39444M 20.5x 1.6x
FICO Unlock Forecast - 30 Days FREE Trial $37756M 61.5x -33.2x
FIS Unlock Forecast - 30 Days FREE Trial $32411M 406.3x 2.3x
FLYW Unlock Forecast - 30 Days FREE Trial $1613M 242.6x 2.0x
FOUR Unlock Forecast - 30 Days FREE Trial $117M -87.9x 0.1x
FVRR Unlock Forecast - 30 Days FREE Trial $836M x 2.1x
GBUX Unlock Forecast - 30 Days FREE Trial $20M x x
GETY Unlock Forecast - 30 Days FREE Trial $842M 60.6x 1.4x
GPN Unlock Forecast - 30 Days FREE Trial $19207M 21.8x 0.9x
HGBL Unlock Forecast - 30 Days FREE Trial $53M 14.7x 0.8x
HQY Unlock Forecast - 30 Days FREE Trial $8162M 57.0x 3.8x
IIIV Unlock Forecast - 30 Days FREE Trial $1062M 76.4x 2.8x
IMXI Unlock Forecast - 30 Days FREE Trial $437M 12.7x 3.1x
INVU Unlock Forecast - 30 Days FREE Trial $53M x 3.0x
INVUP Unlock Forecast - 30 Days FREE Trial $48727M x 2799.1x
JANL Unlock Forecast - 30 Days FREE Trial $43M 13.2x 1.9x
LQDT Unlock Forecast - 30 Days FREE Trial $882M 33.7x 4.2x
LUCN Unlock Forecast - 30 Days FREE Trial $35M x x
LYFT Unlock Forecast - 30 Days FREE Trial $8491M 94.6x 11.6x
MA Unlock Forecast - 30 Days FREE Trial $505222M 38.5x 64.3x
MAX Unlock Forecast - 30 Days FREE Trial $847M -28.2x 203.0x
MCOM Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
MDCE Unlock Forecast - 30 Days FREE Trial $1M x x
MELI Unlock Forecast - 30 Days FREE Trial $116397M 53.1x 20.4x
MMS Unlock Forecast - 30 Days FREE Trial $4798M 15.6x 2.7x
MOGU Unlock Forecast - 30 Days FREE Trial $3856M x 6.4x
MSCI Unlock Forecast - 30 Days FREE Trial $42668M 35.5x -46.8x
NUTX Unlock Forecast - 30 Days FREE Trial $702M 10.3x 3.6x
OLO Unlock Forecast - 30 Days FREE Trial $1851M -64.3x 2.6x
OPRX Unlock Forecast - 30 Days FREE Trial $364M -4.6x 3.1x
PAY Unlock Forecast - 30 Days FREE Trial $3953M 71.7x 7.7x
PAYO Unlock Forecast - 30 Days FREE Trial $2126M 22.0x 2.8x
PAYS Unlock Forecast - 30 Days FREE Trial $283M 47.7x 6.7x
PDD Unlock Forecast - 30 Days FREE Trial $654414M x 23.0x
PHR Unlock Forecast - 30 Days FREE Trial $1376M -20.5x 4.6x
PRTH Unlock Forecast - 30 Days FREE Trial $557M 16.7x -3.7x
PRTHU Unlock Forecast - 30 Days FREE Trial $603M 16.3x x
PSFE Unlock Forecast - 30 Days FREE Trial $652M x 0.8x
PYPL Unlock Forecast - 30 Days FREE Trial $65569M 14.3x 3.3x
QH Unlock Forecast - 30 Days FREE Trial $5633M x 13.7x
QNST Unlock Forecast - 30 Days FREE Trial $818M -42.4x 3.5x
RBA Unlock Forecast - 30 Days FREE Trial $18525M 45.4x 3.4x
RDWR Unlock Forecast - 30 Days FREE Trial $1086M x 3.4x
RELY Unlock Forecast - 30 Days FREE Trial $3355M 254.5x 4.4x
RPAY Unlock Forecast - 30 Days FREE Trial $416149M -10.6x 656.7x
RSKD Unlock Forecast - 30 Days FREE Trial $814M x 2.1x
RSSS Unlock Forecast - 30 Days FREE Trial $107M 84.4x 7.7x
SCOR Unlock Forecast - 30 Days FREE Trial $37M -0.4x -2.0x
SEZL Unlock Forecast - 30 Days FREE Trial $2392M 25.0x 18.4x
SRCO Unlock Forecast - 30 Days FREE Trial $6M x x
TC Unlock Forecast - 30 Days FREE Trial $8474M x 256.9x
TCOM Unlock Forecast - 30 Days FREE Trial $47620M x 2.9x
TDTH Unlock Forecast - 30 Days FREE Trial $472M x x
TIC Unlock Forecast - 30 Days FREE Trial $1494M x 1.3x
TNET Unlock Forecast - 30 Days FREE Trial $2826M 21.5x 25.7x
TRPCF Unlock Forecast - 30 Days FREE Trial $44012M x 2.7x
UBER Unlock Forecast - 30 Days FREE Trial $199829M 15.6x 8.8x
UK Unlock Forecast - 30 Days FREE Trial $1M x 0.0x
UXIN Unlock Forecast - 30 Days FREE Trial $3377M x x
WAI Unlock Forecast - 30 Days FREE Trial $24M x 0.7x
WEX Unlock Forecast - 30 Days FREE Trial $5284M 17.4x 5.4x
WNS Unlock Forecast - 30 Days FREE Trial $3460M x 4.3x
WRPT Unlock Forecast - 30 Days FREE Trial $20M x 144.5x
WU Unlock Forecast - 30 Days FREE Trial $3038M 3.2x 26.7x
XBP Unlock Forecast - 30 Days FREE Trial $18M x -1.8x
XHLD Unlock Forecast - 30 Days FREE Trial $9M x 1.7x
XMTR Unlock Forecast - 30 Days FREE Trial $2480M -24.7x 7.9x
ZG Unlock Forecast - 30 Days FREE Trial $17487M -134.7x 3.7x

Frequently Asked Questions - Xometry, Inc. Stock Forecast

How accurate are Xometry, Inc. stock predictions?

Our AI model shows a 56% Spearman correlation coefficient for XMTR predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Xometry, Inc. stock price forecasts?

Our analysis considers Xometry, Inc.'s financial metrics, Trade & Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Xometry, Inc. a good investment in 2025?

Based on our AI analysis, Xometry, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Xometry, Inc. forecasts updated?

Xometry, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Xometry, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Xometry, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...